ID   KPC-IL-6 KO
AC   CVCL_UR56
SY   KPC-IL-6KO
DR   Wikidata; Q95980100
RX   PubMed=33851955;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R172H:Pdx1-Cre (KPC).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 5
//
RX   PubMed=33851955; DOI=10.1084/jem.20190450; PMCID=PMC8185651;
RA   Rupert J.E., Narasimhan A., Jengelley D.H.A., Jiang Y.-L., Liu J.-G.,
RA   Au E., Silverman L.M., Sandusky G., Bonetto A., Cao S., Lu X.-Y.,
RA   O'Connell T.M., Liu Y.-L., Koniaris L.G., Zimmers-Koniaris T.A.;
RT   "Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle
RT   mediate pancreatic cancer cachexia.";
RL   J. Exp. Med. 218:e20190450.1-e20190450.23(2021).
//